Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:15:17 EDT Mon 14 Jul 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

C:BNXT - BioNxt Solutions Inc. - https://bionxt.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BNXT - C  1.50.55·0.562.00.55-0.05-8.3146.177690.57  0.57  0.540.69  0.1815:39:28Jul 1115 min RT 2¢
CSE - C1.50.55·0.562.00.55-0.05-8.380.643290.57  0.57  0.540.69  0.1815:39:2815 min
NEO ATS - U 0.55-0.05-8.320.01180.56  0.56  0.5513:23:4715 min
Omega - O 0.56-0.04-6.715.0890.57  0.57  0.5513:26:4815 min
CX2 - H 0.56-0.04-6.728.515180.57  0.57  0.5513:26:4815 min
CXD - D 0.565-0.035-5.80.5010.565  0.565  0.56510:29:2515 min
TriAct - M 0.601.514    15 min

Recent Trades - Last 10 of 69
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:58:28O0.52-0.081,0001 Anonymous2 RBCK
15:58:28U0.55-0.052,0002 RBC2 RBCK
15:58:28U0.55-0.052,0002 RBC2 RBCK
15:39:28C0.55-0.051,0002 RBC1 AnonymousK
15:08:46M0.55-0.05462 RBC1 AnonymousE
13:26:48H0.56-0.041,5007 TD Sec1 AnonymousK
13:26:48H0.56-0.041,0002 RBC1 AnonymousK
13:26:48H0.56-0.045001 Anonymous1 AnonymousK
13:26:48C0.56-0.041,0001 Anonymous1 AnonymousK
13:26:48H0.56-0.045001 Anonymous1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-11 18:20C:BNXT0.60News ReleaseBionxt arranges $1.2-million debenture unit financing
2025-07-08 21:28C:BNXT0.54News ReleaseBioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology
2025-07-07 13:42C:BNXT0.55News ReleaseBionxt Solutions receives cladribine API for BNT23001
2025-06-27 20:00C:BNXT0.53News ReleaseBionxt Solutions mgmt cease trade order revoked
2025-06-26 17:07C:BNXT0.52SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-06-26 17:07C:BNXT0.52SEDAR Interim MD & ASEDAR Interim MD & A
2025-06-25 19:38C:BNXT0.52SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 19:38C:BNXT0.52SEDAR MD & ASEDAR MD & A
2025-06-23 09:57C:BNXTNews ReleaseBionxt begins FS for semaglutide oral thin film
2025-06-12 03:01C:BNXT0.55News ReleaseBionxt has no material changes
2025-05-29 20:50C:BNXT0.55News ReleaseBionxt has no material changes
2025-05-23 08:59C:BNXT0.53News ReleaseBionxt receives notice of intention for patent grant
2025-05-15 19:31C:BNXT0.51News ReleaseBionxt Solutions Provides Bi-Weekly MCTO Status Report
2025-05-13 11:34C:BNXT0.485News ReleaseBionxt Solutions expands R&D work to Gen-Plus
2025-05-05 09:13C:BNXT0.435News ReleaseBionxt filing accepted by Eurasian Patent Organization
2025-05-02 05:40C:BNXT0.43News ReleaseBionxt late to file 2024 results, receives MCTO
2025-04-23 09:51C:BNXT0.435News ReleaseBionxt prepares for MS human bioequivalence study
2025-03-14 19:13C:BNXT0.57News ReleaseBionxt closes $900,000 final tranche of placement
2025-02-28 19:46C:BNXT0.51News ReleaseBionxt closes first tranche of debenture unit financing
2025-02-24 18:09C:BNXT0.50News ReleaseBionxt arranges $2.5-million debenture unit financing